C - Chemistry – Metallurgy – 12 – P
Patent
C - Chemistry, Metallurgy
12
P
167/37, 195/1.11
C12P 21/08 (2006.01) C07K 7/64 (2006.01) C07K 16/44 (2006.01) C12N 5/12 (2006.01) G01N 33/577 (2006.01)
Patent
CA 1309671
ABSTRACT Novel monoclonal antibodies capable of distinguishing between cyclosporins, e.g. Cyclosporine, and metalbolites, e.g. Cyclo- sporins 17 and 18, are produced, e.g. starting from novel cyclosporins having an activated coupling group, e.g. activated carboxy group, e.g. (i) [(0-succinimidooxysuccinyl)-Thr]2- Cyclosporine and (ii) [(N-.epsilon.-succinimidooxysuccinyl)-(D)Lys]8- Cyclosporine. Cyclosporin starting materials required for the production of cyclosporins of type (ii), e.g. [(D)Lys]8-Cyclo- sporine are also new and additionally have utility in the preparation of novel labelled cyclosporin derivatives, as well as antibodies and antisera generally. Also claimed are novel antigenic conjugates and hybridoma cell lines used in the production of antibodies and antisera as aforesaid as well as assay kits comprising novel antisera, antibodies and/or labelled cyclosporins as aforesaid.
492047
Ball Philipp E.
Quesniaux Valerie
Rosenthaler Joachim
Schreier Max H.
Wenger Roland
Ball Philipp E.
Fetherstonhaugh & Co.
Novartis Ag
Quesniaux Valerie
Rosenthaler Joachim
LandOfFree
Monoclonal antibodies to cyclosporins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoclonal antibodies to cyclosporins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibodies to cyclosporins will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1169537